Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis.
about
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysisPrognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysisUse and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort.Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.Recent Advances in the Neoadjuvant Treatment of Breast Cancer.Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments.Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.Standardizing of Pathology in Patients Receiving Neoadjuvant Chemotherapy.Anti-HER2 CD4+ T-Helper Type 1 Immune Response is Superior to Breast MRI for Assessing Response to Neoadjuvant Therapy in Patients with HER2-Positive Breast Cancer.Adjuvant trastuzumab: a 10-year overview of its benefit.A single-institution experience of salvage therapy for patients with early and locally advanced breast cancer who progress during neoadjuvant chemotherapy.Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis.MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy.Tumor Infiltrating Lymphocytes in Breast Cancer Patients with Progressive Disease during Neoadjuvant Chemotherapy.Is complete response the answer?Neoadjuvant chemotherapy regimens in treatment of breast cancer: a systematic review and network meta-analysis protocol.Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey
P2860
Q33815986-822F5258-6AD9-4D9F-9248-E49A5713FD7CQ36284245-04413D3E-20C7-4DF5-B940-115D9BFDADD3Q37612139-B8F55A55-FD5C-4424-B09E-78448CB97F6EQ38645144-4A440674-697B-4046-A197-E7F400FE25BAQ38687392-A47C055F-AC2F-44DD-B5C5-E20B05B81F2CQ38737416-1047E1C3-BABB-4E8C-97BD-AD3DD2FF99C7Q38792016-C7E6E891-16CB-48FA-AB00-97BF48B7DA8DQ38886900-56AF8846-BDCF-4ED2-A204-E04E36C4A33AQ39003439-C3E4F53A-B627-409A-AF5F-E9CE3B9C6787Q39018742-39A22AE6-4330-4B66-98C9-8717DCECF4DEQ39154012-A1BA7F19-0149-4317-867F-D25FEE55E4D3Q39375196-DF254215-8FA0-44E7-9F52-A4AF6F7B2D27Q47101783-771C5E4C-435F-4074-B62E-B59056B4F414Q47389056-885C8D5A-6BF2-4CF2-8E00-2DA983D29889Q49987138-1A58ADA3-4843-4726-99B5-C506841CF832Q54467225-C536C287-A997-42CD-A496-0681217769C3Q55466335-EB02F0C9-DB15-49D5-9078-29B721B39AD2Q58783263-7F328EFD-6CA6-4C74-8FF7-6F86058E8739
P2860
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Association of Pathologic Comp ...... erm Outcomes: A Meta-Analysis.
@ast
Association of Pathologic Comp ...... erm Outcomes: A Meta-Analysis.
@en
type
label
Association of Pathologic Comp ...... erm Outcomes: A Meta-Analysis.
@ast
Association of Pathologic Comp ...... erm Outcomes: A Meta-Analysis.
@en
prefLabel
Association of Pathologic Comp ...... erm Outcomes: A Meta-Analysis.
@ast
Association of Pathologic Comp ...... erm Outcomes: A Meta-Analysis.
@en
P2093
P1433
P1476
Association of Pathologic Comp ...... erm Outcomes: A Meta-Analysis.
@en
P2093
Alexander Paterson
Anna McGlothlin
Christine Brezden-Masley
Daniel Rayson
Donald A Berry
Jean-François Boileau
Karen Gelmon
Kristine R Broglio
Margaret Foster
Melanie Quintana
P304
P356
10.1001/JAMAONCOL.2015.6113
P577
2016-02-25T00:00:00Z